ABBV vs TMO: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
AbbVie Inc. · Healthcare
$216.63
+3.8% upside to fair value
Grade C
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
TMO trades at a lower forward P/E
(25.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
TMO |
| Current Price |
$216.63 |
$464.61 |
| Fair Value Estimate |
$224.76 |
$498.27 |
| Upside to Fair Value |
+3.8%
|
+7.2%
|
| Market Cap |
$382.7B |
$172.7B |
| Forward P/E |
106.2x
|
25.2x
|
| EV / EBITDA |
26.4x
|
19.1x
|
| Price / Sales |
6.1x
|
3.8x
|
| Price / FCF |
18.3x
|
25.6x
|
| Revenue Growth YoY |
+12.4%
|
+6.2%
|
| Gross Margin |
70.7%
|
39.4%
|
| Operating Margin |
27.6%
|
17.8%
|
| Return on Equity |
68.0%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.45%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in pharmaceuticals with a strong focus on immunology, aesthetics, neuroscience, and oncology. The company benefits from a durable competitive moat driven by its immunology franchises, global commercial scale, and R&D capabilities, although it faces challenges from the post-Humira patent cliff and intense competition in biologics and small m…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
ABBV |
TMO |
| Zone Low |
$168.57 |
$373.70 |
| Zone High |
$191.05 |
$423.53 |
| In Buy Zone? |
No
|
No
|